INTRODUCTION Several novel variants of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the virus that causes COVID-19, emerged in late 2020. One of these, …

Background In December, 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
a novel coronavirus, emerged in Wuhan, China. Since then, the city of Wuhan has …

Background The risk of severe COVID-19 if an individual becomes infected is known to be
higher in older individuals and those with underlying health conditions. Understanding the …

Background The isolation of symptomatic cases and tracing of contacts has been used as
an early COVID-19 containment measure in many countries, with additional physical …

Background Non-pharmaceutical interventions have been implemented to reduce transmission
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the UK. Projecting …

A novel SARS-CoV-2 variant, VOC 202012/01, emerged in southeast England in November
2020 and is rapidly spreading towards fixation. Using a variety of statistical and dynamic …

Background National immunisation programmes globally are at risk of suspension due to the
severe health system constraints and physical distancing measures in place to mitigate the …

Background: Interventions are now in place worldwide to reduce transmission of the novel
coronavirus. Assessing temporal variations in transmission in different countries is essential …

The outbreak of monkeypox across non-endemic regions confirmed in May 2022 shows
epidemiological features distinct from previously imported outbreaks, most notably its observed …

Background In most countries, contacts of confirmed COVID-19 cases are asked to quarantine
for 14 days after exposure to limit asymptomatic onward transmission. While theoretically …